Lantheus Holdings (LNTH) Net Income Growth (5y) (2019 - 2026)
Lantheus Holdings (LNTH) Net Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.44 Bn | 30.50 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.99 Bn | 6.49 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67.40% |
| Dec 31, 2025 | 112.81% |
| Sep 30, 2025 | 44.72% |
| Jun 30, 2025 | 67.62% |
| Mar 31, 2025 | 85.32% |
| Dec 31, 2024 | -103.62% |
| Sep 30, 2024 | 93.31% |
| Jun 30, 2024 | 57.46% |
| Mar 31, 2024 | 67.47% |
| Dec 31, 2023 | 63.25% |
| Sep 30, 2023 | 70.09% |
| Jun 30, 2023 | 57.39% |
| Mar 31, 2023 | -18.55% |
| Dec 31, 2022 | -26.40% |
| Sep 30, 2022 | 48.34% |
| Jun 30, 2022 | 25.93% |
| Mar 31, 2022 | 59.68% |
| Dec 31, 2021 | -59.08% |
| Sep 30, 2021 | -38.95% |
| Jun 30, 2021 | -41.27% |